Financial reports
10-K
2023 FY
Annual report
12 Mar 24
10-Q
2023 Q3
Quarterly report
9 Nov 23
10-Q
2023 Q2
Quarterly report
8 Aug 23
10-Q
2023 Q1
Quarterly report
11 May 23
10-K
2022 FY
Annual report
1 Mar 23
10-Q
2022 Q3
Quarterly report
8 Nov 22
10-Q
2022 Q2
Quarterly report
10 Aug 22
10-Q
2022 Q1
Quarterly report
11 May 22
10-K
2021 FY
Annual report
8 Mar 22
10-Q
2021 Q3
Quarterly report
10 Nov 21
Current reports
8-K
ClearPoint Neuro Reports Fourth Quarter and Full-Year 2023 Results
12 Mar 24
8-K
Entry into a Material Definitive Agreement
1 Mar 24
8-K
ClearPoint Neuro Reports Fourth Quarter and Full Year 2023 Preliminary Revenue Results and Guidance for Full Year 2024 Revenue
8 Jan 24
8-K
ClearPoint Neuro Reports Third Quarter 2023 Results
9 Nov 23
8-K
ClearPoint Neuro Reports Second Quarter 2023 Results
8 Aug 23
8-K
Entry into a Material Definitive Agreement
1 Aug 23
8-K
Amendments to Articles of Incorporation or Bylaws
25 May 23
8-K
Other Events
22 May 23
8-K
ClearPoint Neuro Reports First Quarter 2023 Results
11 May 23
8-K
Entry into a Material Definitive Agreement
3 Mar 23
Registration and prospectus
424B2
Prospectus for primary offering
1 Mar 24
424B5
Prospectus supplement for primary offering
28 Feb 24
S-3
Shelf registration
13 Nov 23
S-8
Registration of securities for employees
1 Jun 22
S-8
Registration of securities for employees
4 Jun 21
424B5
Prospectus supplement for primary offering
19 Feb 21
424B5
Prospectus supplement for primary offering
18 Feb 21
S-3
Shelf registration
22 Jan 21
S-8
Registration of securities for employees
3 Jun 20
25
Voluntary exchange delisting
6 Dec 19
Proxies
DEF 14A
Definitive proxy
5 Apr 24
DEF 14A
Definitive proxy
14 Apr 23
PRE 14A
Preliminary proxy
3 Apr 23
DEF 14A
Definitive proxy
11 Apr 22
PRE 14A
Preliminary proxy
31 Mar 22
DEFA14A
Additional proxy soliciting materials
14 May 21
DEF 14A
Definitive proxy
19 Apr 21
DEF 14A
Definitive proxy
20 Apr 20
DEFA14A
Additional proxy soliciting materials
21 May 19
DEFA14A
Additional proxy soliciting materials
17 May 19
Other
EFFECT
Notice of effectiveness
21 Nov 23
CORRESP
Correspondence with SEC
17 Nov 23
UPLOAD
Letter from SEC
16 Nov 23
CT ORDER
Confidential treatment order
15 Dec 21
EFFECT
Notice of effectiveness
1 Feb 21
CORRESP
Correspondence with SEC
27 Jan 21
UPLOAD
Letter from SEC
27 Jan 21
CERT
Certification of approval for exchange listing
6 Dec 19
CERT
Certification of approval for exchange listing
2 Jul 19
CT ORDER
Confidential treatment order
27 Nov 18